The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 13,975 | 9,911,577 | SH | SOLE | 9,911,577 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 800 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 65,554 | 6,069,775 | SH | SOLE | 6,069,775 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 2,410 | 52,290 | SH | SOLE | 52,290 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 8,202 | 2,297,360 | SH | SOLE | 2,297,360 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 9,704 | 1,151,163 | SH | SOLE | 1,151,163 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 3,926 | 525,531 | SH | SOLE | 525,531 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM | 05338F108 | 2,567 | 1,510,095 | SH | SOLE | 1,510,095 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 3,158 | 239,433 | SH | SOLE | 239,433 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,936 | 2,311,530 | SH | SOLE | 2,311,530 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 11,245 | 14,768,823 | SH | SOLE | 14,768,823 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 21,825 | 8,800,358 | SH | SOLE | 8,800,358 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,014 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 4,456 | 1,194,670 | SH | SOLE | 1,194,670 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 12,129 | 1,863,096 | SH | SOLE | 1,863,096 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 9,985 | 858,567 | SH | SOLE | 858,567 | 0 | 0 | ||
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | COM NEW | 64130M209 | 967 | 498,354 | SH | SOLE | 498,354 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 6,228 | 3,844,230 | SH | SOLE | 3,844,230 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 12,860 | 4,006,185 | SH | SOLE | 4,006,185 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 3,864 | 808,405 | SH | SOLE | 808,405 | 0 | 0 | ||
| SYNLOGIC INC | COM | 87166L100 | 2,575 | 1,064,135 | SH | SOLE | 1,064,135 | 0 | 0 | ||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 16,573 | 5,656,373 | SH | SOLE | 5,656,373 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 960 | 46,026 | SH | SOLE | 46,026 | 0 | 0 | ||